glp-1 drugs and parkinson's disease Are we measuring the wrong primary outcome for for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep Role of glucagon-like peptide-1 receptor
Pay in 4 interest-free payments of $6.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8


















:max_bytes(150000):strip_icc()/VWH-GettyImages-2190414326-0d878e64bbf84b179058fbdc220cf21e.jpg)






